Triana Biomedicines - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTriana Biomedicines
Triana Biomedicines logo

Triana Biomedicines

0 followers

About Triana Biomedicines

Triana Biomedicines is a biotechnology company that discovers and develops molecular glue therapeutics for the targeted degradation of high‑profile cancer proteins. It employs a target‑first, rational discovery platform to create oncology drugs and is headquartered in Waltham, Massachusetts, United States.

Recent News

Recent Deals

Key Team Members

Patrick Trojer, PhD

President & Chief Executive Officer

Caroline Germa, MD

Chief Medical Officer

Key Facts

HQ Location

Waltham, United States

Founded

2019

Employees

51 - 200

Status

Private

Website

https://trianabio.com